Brandon Cornelius
Obstetrics & Gynecology · Dallas, TXNPI 1619292455
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Astellas Pharma US Inc at 43.3% of the total. Reporting peaked in 2024 at $236 and has fallen 83.1% since, to $40 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.
Across 11 payments — averaging $38.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$181
- Hologic Sales And Service, LLC$57
- Johnson & Johnson$50
- Organon$34
- Immunogen, Inc.$22
- Sage Therapeutics, LLC$21
- plus $54 from 3 others
What the payments were for
- Food & beverage$23757%
- Education$18143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 2 | $181 |
| Hologic Sales And Service, LLC | 1 | $57 |
| Johnson & Johnson | 2 | $50 |
| Organon | 1 | $34 |
| Immunogen, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Meditrina | 1 | $19 |
| AstraZeneca | 1 | $14 |
How this compares
$418 in reported general payments places this provider in the 35th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 28 | $1,266 |
| ProgesteroneProgesterone, Micronized | 21 | $596 |
| Clobetasol Propionate | 31 | $338 |
| Imiquimod | 13 | $233 |
| Tramadol Hcl | 23 | $56 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dallas
- Dale StovallDallas$590K
- Quanita CrableDallas$176K
- Kamilia SmithDallas$119K
- Yolanda LawsonDallas$96K
- Patrick WeixDallas$96K
- David RogersDallas$44K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.